logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10221129 B1

PDFFull Text
Date of Patent:
Mar. 05, 2019

Filed:

Apr. 22, 2016

Inhibitors of human immunodeficiency virus replication

Applicant:

Viiv Healthcare Uk (No.5) Limited, Brentford, Middlesex, GB;

Inventors:

John A. Bender, Wallingford, CT (US);

Robert G. Gentles, Wallingford, CT (US);

Annapurna Pendri, Wallingford, CT (US);

Alan Xiangdong Wang, Wallingford, CT (US);

Nicholas A. Meanwell, Wallingford, CT (US);

Brett R. Beno, Wallingford, CT (US);

Robert A. Fridell, Wallingford, CT (US);

Makonen Belema, Wallingford, CT (US);

Van N. Nguyen, Auburn, MI (US);

Zhong Yang, Southington, CT (US);

Gan Wang, Cheshire, CT (US);

Selvakumar Kumaravel, Bangalore, IN;

Srinivasan Thangathirupathy, Bangalore, IN;

Rajesh Onkardas Bora, Bangalore, IN;

Shilpa Maheshwarappa Holehatti, Bangalore, IN;

Mallikarjuna Rao Mettu, Bangalore, IN;

Manoranjan Panda, Bangalore, IN;

Assignee:

VIIV HEALTHCARE UK (NO.5) LIMITED, Brentford, Middlesex, GB;

Attorneys:

Robert H. Brink

Kathryn A. Lutomski

Edward R. Gimmi

Primary Examiner:

Venkataraman Balasubramanian

Int. Cl.
CPC ...
C07C 307/06 (2006.01); C07C 307/10 (2006.01); C07C 311/08 (2006.01); A61P 31/18 (2006.01); A61K 31/65 (2006.01); C07D 215/12 (2006.01); C07D 215/38 (2006.01); C07D 217/08 (2006.01); C07D 217/22 (2006.01); C07D 231/12 (2006.01); C07D 231/56 (2006.01); C07D 233/64 (2006.01); C07D 333/72 (2006.01); C07D 235/08 (2006.01); C07D 241/04 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 249/12 (2006.01); C07D 471/04 (2006.01); C07D 261/08 (2006.01); C07D 263/32 (2006.01); C07D 205/04 (2006.01); C07D 207/325 (2006.01); C07D 277/28 (2006.01); C07D 498/04 (2006.01); C07D 209/08 (2006.01); C07D 277/62 (2006.01); C07D 209/30 (2006.01); C07D 209/32 (2006.01); C07D 209/86 (2006.01); C07D 295/185 (2006.01); C07D 211/96 (2006.01); C07D 295/26 (2006.01); C07D 213/42 (2006.01);
U.S. Cl.
CPC ...
C07C 307/06 (2013.01); A61P 31/18 (2018.01); C07C 307/10 (2013.01); C07C 311/08 (2013.01); C07D 205/04 (2013.01); C07D 207/325 (2013.01); C07D 209/08 (2013.01); C07D 209/30 (2013.01); C07D 209/32 (2013.01); C07D 209/86 (2013.01); C07D 211/96 (2013.01); C07D 213/42 (2013.01); C07D 215/12 (2013.01); C07D 215/38 (2013.01); C07D 217/08 (2013.01); C07D 217/22 (2013.01); C07D 231/12 (2013.01); C07D 231/56 (2013.01); C07D 233/64 (2013.01); C07D 235/08 (2013.01); C07D 241/04 (2013.01); C07D 249/12 (2013.01); C07D 261/08 (2013.01); C07D 263/32 (2013.01); C07D 277/28 (2013.01); C07D 277/62 (2013.01); C07D 295/185 (2013.01); C07D 295/26 (2013.01); C07D 333/72 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 498/04 (2013.01); C07C 2601/14 (2017.05); C07C 2602/08 (2017.05);
Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

Find Patent Forward Citations

Loading…